Abhishek Mehra
at Till Advisors
Replay available
DMCC Speciality Chemicals (NSE:DMCC) Q2 2027 earnings call, held 2026-11-18. Watch the replay and read the transcript on 6ix.

On 6ix: 6ix.com/event/dmcc-speciality-chemicals-limited-dmcc-q2-2027-earnings-call
Automated transcript · Written by software from the replay's audio. It can mishear names and figures; the replay is the record.
0:01 Ladies and gentlemen, good day, and welcome to Q2 and H1 FY 'twenty seven Earnings Conference Call of DMCC SPECIALITY CHEMICALS LIMITED, hosted by Till Advisors. As a reminder, all participant lines will be in the listen only mode and there will be an opportunity for you to ask questions after the presentation concludes.
0:29 Please note that this conference is being recorded. I now hand the conference over to Mr. Abhishek Mehra from Till Advisors. Thank you, and over to you, Mr. Mehra. Thank you. Good evening, and welcome, everyone. Thank you for joining this Q2 and H1 FY 'twenty seven earnings conference call of DMCC SPECIALITY CHEMICALS LIMITED. The investor updates have already been uploaded on the stock exchange and on the company website. In case you do not have a copy of the same, please feel free to reach out to us. To take us through the discussion we have discussed from the management team, Mr. Biman Goghaldas, Managing Director and CEO Mr. Sunil Gurir, Chief Financial Officer and Mr. Pallavi Padnekar, Company Secretary and Compliance Officer. We'll be starting the call with a brief overview of the business performance, which will then be followed by the Q and A session.
1:16 I would like to remind you all that everything set in this call reflecting any outlook for the future, which can be construed as a forward looking statement must be viewed in conjunction with the risks and uncertainties that the company faces. These risks and uncertainties have been mentioned in our annual report. With that said, I'll now hand over the call to Mr. Pindran Gupta for opening comments. Over to you, sir.
1:38 Thank you, Abhishek. So good afternoon, ladies and gentlemen. Thank you for taking the time to attend this call. I'm Bimal Gokul Das, Managing Director and CEO of DMCC. I will take you I will give some of my comments on this quarter. First of all, I'd like to apologize for the late conference call. We should have had this much earlier, but there were some preplanned travel. So we decided to post the commentary online and then have the call at a convenient time. So I'll begin with discussing the results for the quarter. As you could see, the top line was quite high. It was about INR $2.73 crores, but the EBITDA was only INR 11.6 crores, and that's a sharp drop from the previous quarter.
2:38 As I mentioned in the commentary, the main reason for the decline is twofold actually. One is that the prices of sulphur became so high that the sulphuric acid made from that sulphur could not be absorbed by the end use markets. So there was demand destruction at these prices. Just to refresh your memory, before the Iran crisis, sulfur was at about $500 per tonne. After the Iran crisis, it went up to as high as $1,100 $1,200 per tonne.
3:25 And now it has started tapering off, but the entire quarter, it was at elevated levels. In Q1, we were able to pass on the price increases, but we couldn't do that in Q2. The second reason is that we also ran the plants at lower capacity because we didn't see the sense in selling below cost additional volumes. So we rationalized the production. You may have also seen that the working capital increased dramatically compared to the previous year and compared to previous quarter, which is in line with the
4:10 increased price of the raw materials as well as the increased receivables due to the higher top line. In terms of the downstream product, the specialty chemicals business, the results don't reflect it, but we had pretty good traction. We've recovered a lot of overseas markets in new countries, and we continue to do well in that regard. The whole thing got overshadowed by the sulphur price. And I, in fact, recently attended a conference on sulphur and sulphuric acid, and it was sort of reassuring to see that it was not only India which was affected, but also globally, there was demand destruction.
5:07 And one of the presentations I had seen was that above a price of about INR 30,000 per tonne equivalent of sulphuric acid, there is significant demand destruction, which is exactly what we witnessed in India. And now that price is coming off, we expect that there will be an increase in demand again. And in fact, we have seen some of that already. So unfortunately, whatever we did on the specialty chemical side was overshadowed by the sulphur price volatility.
5:54 And that's the result you see in the Q2 performance. With that, I'd like to open up to any questions that you might have had.
6:10 Thank you. We will now begin the question and answer session. The first question comes from the line of Yuk Jain, an individual investor. Please go ahead. Thank you, sir, for the opportunity. Am I audible?
6:46 Yes. Yes. So I would like to start with like earnings quality because that's where I think most of us are struggling. In Q1, you were candid that part of the 13.5% margin came from inventory gain, and you said that they would reverse. Q2 came in at 4%. So across the half, that's about 8% to 8.5% EBITDA on roughly $5.25 crores of revenue. So I am trying to understand, firstly, how much of the Q2 fall was
7:19 that reversal? Second, how much was the sulfur and sulfuric acid spread collapsing? And third, how much fixed cost spread over lower output because you choose to run the plants lower? Even a rough split would help us work out what a normal year looks like.
7:39 Sure. So what you can do, the best way is to look at the delta between the sales and the raw material cost. And that has shrunk. So the gross margin has shrunk substantially between the two quarters. And while we don't give a specific breakup for each individual product, I had already mentioned at the end of Q1 that the inventory gains cannot continue. Inventory gains were in the sense, I'll just refresh your memory on that. Basically, if sulphur goes up,
8:22 I'm selling sulphuric acid at a higher price. And whatever inventory I have, that will get sold at a higher price in terms of sulphuric acid. In this quarter, the price remained high and it remained at a level where there was demand disruption. So for example, if our plant capacity is 100, we ran at about 65%. So we were not it was it didn't make sense to run at a higher capacity, but that also meant that we don't we didn't get the utilities from the sulphuric acid plant that we would have got as in a normal time.
9:11 So there's a it's a combination effect. It's not if we are losing money on variable cost of sulphur, the question of absorption of overheads is not relevant. And this is what happened in the quarter. Okay, understood.
9:31 Sir, secondly, on the specialty transition, in earlier calls, you had mentioned that 50% specialty revenue split with DMCC becomes a true specialty company. True. 27%, but with bulk prices this high, the revenue mix probably understated the progress. You look at one more gross contribution instead, where does specialty actually stands today? And without like asking, could you just outline the road map to 50%, which market, which products or roughly what time frame that we can reach to the 50%? So let me give
10:15 you a very simple way to look at it. The if you go back to the prewar levels, you put sulphur back to $500 per tonne, okay, then we'll be very close to fifty-fifty, okay? So we are at that level already. Unfortunately, this whole this war situation has completely skewed the numbers. And in terms of even the percentage margin, I mean INR $2.70 crores turnover for the quarter is equal to 1,000 crores for the year, but that is not our normal operating level.
11:03 The previous year was
11:05 much lower, and we would have been somewhere above that, of course. We are growing in the specialty business. We are growing in the boron business. But the increase in price of sulphur is purely a mathematical number because of increase I mean, in price of sulphuric acid and the commodity chemicals is basically a mathematical adjustment for the price of sulphur.
11:32 Okay. Understood. Sir, next question is that decision to like run below the optimum in Q2 seem deliberate. Now if my understanding is correct, asset plants are expensive to slow down and restart. So I am just curious that how you drew the line. Did you protect volumes for contract and specialty customers and cut mainly pulp sales? Or how was that has this worked out?
11:59 Exactly. So we ran the plant acid plant only to the extent needed for the specialties. We do have some leverage on turndown. So we didn't shut down the plants, but we operated at a low level. And we do have the ability to slow down sulphuric acid. And you're right, shutting down and restart is expensive, but we didn't do that. Understood. Sir, my next question is like in the Q4 FY 'twenty six call, you would you have spoken that specialty is limited by the market, not by capacity. If that's the case,
12:45 what are you deliberately doing to accelerate the growth, people on the ground in Latin America and Asia distribution partners, application support?
12:55 And like exports were only about 12% of the revenue in Q2 despite the progress you have described in the new geography. Why has that number been slow to move?
13:06 And like connected to that, I am trying to work out whether Europe is cyclical or structural. If your Europeans are moving production to Asia, the business is not coming back to Europe. Right. So our specialty business is in India and overseas. And
13:29 in terms of absolute numbers, exports are better than previous quarter and the previous year. What your question is about Europe is exactly correct. We believe, I personally believe that it is a structural problem in Europe. I do not see that coming back. I think there are too many issues
13:53 with their energy cost and too many issues on their whole integration sort of falling apart. So unless they decide to make real fundamental changes to protect their chemical industry, I don't see a revival. I know that many countries are trying.
14:16 Great Britain has provided, I think, 300,000,000 for their chemical industry, specifically to do some revival. Europe is more difficult because so many countries have to get together and agree and all those countries don't have a chemical industry. So there's a different people are pulling in different directions. So what we are doing is whatever we have in Europe, we have. We don't expect great growth anymore. We believe that whatever disruption was to happen has happened. And we are exploring other markets. We've had good success in Latin America.
15:02 We've had good success in Japan. We are exploring the Korean market, which we expect to see some developments hopefully soon. And within India as well, we see a good growth in the specialty chemicals area. Sir, Okay. So the Latin American or the Asian orders that are replacing Europe, do they carry the same margins? Or are you giving some quality to hold the volumes? Sorry, could you repeat? I'm just the Latin American or and the Asian orders that are replacing the European,
15:41 don't they carry the similar sort of margins? Or are we giving up some quality to hold the volumes? No, we are able to maintain the margins.
15:52 Okay. So sir, just last one question from my end. How much headroom is still left before you need to commit capital again? And roughly what utilization should operating leverage start to show clearly in the margin?
16:09 Right. So we have different plants for different downstream products. And so different capacity utilizations for the same. But we have at least 25% to 30% room to expand. And in addition, we could do some expansion with very low CapEx. So it's not like any it's not like we have to put up an entire new plant and all that unless we want to do an entirely new product.
16:48 Thank you so much for answering my questions and all the best for the upcoming months. Thank you. Thank you. Next question comes from the line of Ashaf Patel with Molecule Ventures LLP. Please go ahead.
17:07 Thank you for the opportunity, sir. So sir, my first question is I'd like to talk about new products. You mentioned you have started commercial sale of an intermediate for a polymer used in enhanced oil recovery. So could you help us to understand how big this could become? Like what are your aspirations here? And is there any long lead time involving additional qualifications from the customer end as well? Sure. So we have done commercial supplies. The products have been approved. And we expect to get at least on an annualized basis of between INR 25 crores to 50 crores from this single product.
17:57 Okay. And is this single product, single customer? No, single product, multiple customer. Got it. And sir, with regards to the because it is oilfield activity related, so how would it be exposed to the crude price? So I guess if the crude prices is up, there would be more crude oil being pumped, so there would be more consumption. But there would be a requirement anyway, and it's we are sort of entering this business from a zero base. So we are going to take market share from incumbents.
18:44 Got it, sir. And sir, on the Voron side, so you mentioned a couple of specialty products in development. So can you please throw some light on end applications of these products which are under development? So they are in basically in the fine chemical space in Boron. I wouldn't like to say too much more at this time. It is some are catalytic applications, and one of them is gold as an intermediate in agrochem. But
19:22 they are also both of them are developing well. Okay. Okay. And with regards to aspired margin profile for this newer products, how different would it be than the existing margin profile? So substantially better. Nice. Okay. And sir, lastly, on the R and D. So last time you mentioned that R and D spending will go up in coming quarters. So any update on that front, sir? Yes, you will see that. You will see that shortly. That is on course. Okay. Okay. Got it. Sure, sir. Thank you and all the best. Thank you. Thank you. Next question comes from the line of Aditi Bid with YS Wealth Management. Please go ahead.
20:14 Yes. Hi. Good afternoon sir. Good afternoon. So my question is that, sir the interest cost has dropped double year on year as short term borrowings funded working capital. As sulphur is there, how quickly soon that working capital release and also will the freight can go to faster reducing the debt or growth? And what is the most that you would be comfortable carrying in a business in this volatility?
20:41 Sorry, I see as the your audio was not very clear. Could you adjust your mic or something and say the question again? Sorry, sir. For this interruption. So the interest cost my question is that the interest cost has roughly doubled year on year in startup borrowing funded working capital. If sulfur is it, how quickly should that working capital delay?
21:12 And also will the freight gas go to the fast to reducing debt or to growth? And what is the most It's not clear, Aditya. Could you please repeat and just speak a little slowly and speak a little away from the mic, I think. Mr. Bede, your voice is not clear. Your words are not clear. So you're loud, but your words are not clear. Can you speak a little slower? Thank you. Okay, sir.
21:43 Sir, may I audible now? Yes. Okay. So my question is that the interest cost has roughly doubled year on year as short term borrowings funded working capital. As sulphur is this, how will you store that working capital release?
22:03 So your question is about the interest cost and the working capital. And yes, interest cost has gone up mainly because of our requirement of working capital, which is in line with what our top line has grown. So we have approached our banks, and they've been supportive. They've increased our working
22:31 So we are comfortable on the fund availability. But of course, we need to finance the interest, and that is what you're seeing. All the interest cost increase you're seeing is because of the growth in top line and which results in more working capital requirement. In terms of term loans, we are repaying. That is as per schedule. And
22:59 the interest rate, Suneet, could you comment? Yes. So it is ranging from 7.5% to 8.5%. So even that is a normal interest rate, 7.5% to 8.5%. And if you look at our the working capital number of days, that's also under control. I think debtors, we are within forty five days. And so we are trying to run it as tightly as possible. Good, sir. So and my second question is that with respect to the long term borrowing under the government scheme for the businesses affected by the Middle East conflict, could you say that senior and MA conductor attached to that?
23:51 So we took, I think, about INR 9 crores or INR 10 crores. INR ECLGS. And that interest rate was also about 8.5%. Okay. Then the last question is that on the level of the near Ambarna, setting aside the deal in transferring the title, which monetization route are you looking at? So we think of it as likely source of cost for the next CapEx round?
24:22 And by estimate, by where do you think in the most conservative estimates that you would be able to monetize that in parcel?
24:32 So very tough to say because Supreme Court has given the order, but Maharashtra government has still not complied with the order. They are doing some survey and things like this. I can't give an estimate of how long it will take, but we'll have to just wait for it.
24:51 Okay. Understand, sir. It's not only us, it's a whole area. Thank you. Thank you.
25:15 Next question comes from the line of Ashika, an individual investor. Please go ahead. Hello?
25:26 Go ahead. Am I audible?
25:27 Yes. Yes. Good evening, Thank you for the opportunity. So firstly, I wanted to ask two quick questions on the sulphur part first. I actually read somewhere that the Indonesian smelters pulled about 3,000,000 tonnes before Hermes even happened. So does this imply that sulfur will remain tight regardless of The Gulf? And if so, how do we look at the commodity part of the business?
25:57 Yes, that is correct. The Indonesian smelter was picking up material over the past, I think, one years point or two years, which is what resulted in the price of sulphur going up from about $200 to about $500.600 dollars per tonne. And post holders, it went up further to about $1,100.1200 dollars per tonne.
26:23 So for us, we need to finance that sulphur. And for the most part, we were able to pass on the price increase. The challenge was actually, number one, to increase our working capital and manage that so that we could fund the sulphur purchase at a higher price. And the second was, of course, to ensure that we got supplies during the initial stages of the
26:53 Iran prices when supplies became really tight. So we, I think, have been through the worst of it. And I think now prices are softening and availability is also easing. Hopefully, nothing flares up again. All right. And secondly, on the demand destruction in quarter two, so which end markets cracked first? Since sulphur eased from mid October, is that demand fully back?
27:27 Yes. I think one of the first to go was the fertilizer sector. In fact, GSFC, the Gujarat State Fertilizer Corporation, which is actually a net consumer of sulphuric acid. They shut down their fertilizer operations, and they were selling sulphuric acid in the market at a low price. And so fertilizer sector was the first other sectors, including detergents, they also reduced production. And all other downstream chemicals were also in
28:05 difficulty. Okay. October, the situation is easing slowly. We'll have to see. This is not fertilizer season now, but we'll have to see what happens in the coming months. We expect that it will come back because you can't keep fertilizer plants shut down because fertilizer is needed in the country. They'll have to come back now.
28:35 Understood. So coming on the industry structure, you said much of the quarter two market sold below cost, nonintegrated players must have bled. So do you see any consolidation or exits? So nobody has actually exited, but everyone was operating at low capacities in the sulphur business. Okay. Sir, on our integration of using common utilities like steam and power from the asset plants for the specialty plant, when asset runs below optimum, how much does specialty cost per unit rise?
29:19 So right, that's a good question. If we were to completely shut down the sulphuric acid part of it, we would see an increase in cost of perhaps 10% or so on our specialty chemical side. I don't know this offhand, I'm giving you an estimate.
29:43 But as I mentioned, we didn't shut down the plant. We just ran it enough to supply utilities to our own downstream plants. Okay. All right. Thank you. And that's it from my end. All the best for the next quarter. Yeah. Thank you. Thank you.
30:11 Next question comes from the line of Henil Pagadia with Equip Corp. With
30:23 respect to the R and D, I think so we were doing about 2 crores of R and D per annum. So if you could give some more understanding in this R and D expense, how much is actually going towards the new product development because we're actually starting new geographies such as Latin America, some in Asia, Korea, Japan, etcetera. And out there, some of the filings and the product development that we've done for the European markets, are most of those products not I mean, do they have a market in Latin America and other geographies in Asia? Or are they just shelved for now because Europe was the main focus market for that particular product?
31:00 Right. So partly, they have the products have been placed elsewhere and partly we've replaced with other products. So we would have liked to do the other products along with the old ones, but of course, that wasn't possible. In terms of R and D expenditure, at the moment, all of it is going towards the new product development.
31:30 Sir, with respect to the product approval cycles, I think so Europe and Latin America is pretty long Europe and sorry, North America is pretty long. So if you give some understanding on the product cycles for Latin America and Asian countries?
31:47 So even Asian countries, because of people we are supplying to are quite sophisticated end users. And in fact, even the Latin American customers, they belong to multinational companies. So there is or there has been a time lag, but we are past that now for most of the countries. Okay. So we have actually got a product in the portfolio called as a DDS, a four-four DDS that we actually used to do. Are we on path to develop a DC, DPS that I think some of the big guys like Solvay, Bassil, Sumitomo, etcetera, deal into because this is a specialty monomer and it's got a big application in Europe and North American markets?
32:35 That's not our focus at the moment. Sir, lastly, with respect to the sulfur prices, if with the current price at about $800 what kind of number of day stock that we have at the plant right now across both Roha and Dahid?
32:54 See, I can't tell you offhand, but typically we keep fifteen days to twenty days maximum. Okay. And lastly, if the utilization of the plant has actually dropped to about 15%, so one of the previous participant, deduced a similar question. So if the utilization earlier we used to operate about 95%, 100 utilization at sulfuric on the sulfuric acid side. With the current 5060% utilization, what is the delta in terms of the cost? Because I think we used to generate steam and the steam was actually used to regenerate energy and it was used in the plant. So with the fall in both the price realization as well as lower steam generation, what is the net cost delta impact that is on the P and L? So I can't discuss exact numbers, but I can tell you that as a business, sulphuric acid was negative for the quarter.
33:48 Okay. Okay. Thanks a lot, sir. And wish you all the very best. Thank you. Thank you. Ladies and gentlemen, that was the last question for today. We have reached the end of question and answer session. I now hand the conference over to Mr. Bimal Kokuldas for closing comments. Thank you. So thank you, ladies and gentlemen, for attending and for insightful questions as well. It's always a learning for us. And I hope that we've been able to answer you satisfactorily. As always, we don't give forward looking projections, but we'll be happy to answer anything in future on anything in our results.
34:39 Thank you very much. Back to you, Abhishek. Thank you. On behalf of DMCC SPECIALITY CHEMICALS LIMITED, that concludes this conference. Thank you for joining us. You may now disconnect your lines.
Follow DMCC Speciality Chemicals Limited into a list and get an email when it puts out news.
at Till Advisors
Managing Director and CEO
Chief Financial Officer
Company Secretary and Compliance Officer
Managing Director and CEO at DMCC
individual investor
at Molecule Ventures LLP
at YS Wealth Management
at Equip Corp